Schedule 13G ownership disclosure

Terns Pharmaceuticals Inc

Common Stock · CUSIP: 880881107

Event date: 2025-09-30

Filing-level shares
4,559,917
Percent of class
5.21%
  • The Vanguard Group

    Shares: 4,559,917 · Class: 5.21%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-25-000325
Form type
SCHEDULE 13G
Filer
Terns Pharmaceuticals, Inc.
CIK
CIK 1831363
Filed
Oct 31, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub